Abstract
Purpose
The goal of this study was to analyze the incidence of perioperative bleeding complications in rhegmatogenous retinal detachment. The handling of perioperative anticoagulation during vitreoretinal surgery remains controversial, since the risk of bleeding complications by its continuation has to be balanced against the risk of progression of retinal detachment and the risk of thromboembolic events when anticoagulation is interrupted. Nevertheless, only few studies have investigated the risk of perioperative bleeding complications in an emergency such as retinal detachment surgery.
Methods
We therefore examined the rate of all perioperative hemorrhages and separately the rate of only severe bleedings during vitrectomy, scleral buckling with or without drainage of subretinal fluid (SRD), or combined procedures due to retinal detachment in patients undergoing different types of perioperative anticoagulation including acetylsalicylic acetate (ASA), clopidogrel, heparin, low molecular weight heparin, and phenprocoumon.
Results
This retrospective single-center study included 893 patients with primary rhegmatogenous retinal detachment, n = 192 on anticoagulation and n = 701 serving as control without anticoagulation. Our analysis revealed no significantly increased rate of perioperative hemorrhages under anticoagulation with ASA 100 mg (all, 11.4%; severe, 5.0%) or phenprocoumon (all, 11.6%; severe, 2.3%) compared with controls (all, 13.0%; severe, 5.4%). However, frequencies of bleeding complications varied markedly regarding the type of surgical procedure: Scleral buckling plus SRD showed the highest rates of hemorrhages (all, 18.9%; severe, 9.1%) with significant difference (P < 0.001) compared with scleral buckling without SRD (all, 3.8%; severe, 0.6%) and vitrectomy (all, 9.2%; severe, 1.5%), respectively. Furthermore, subretinal bleeding was the most common type of perioperative hemorrhage.
Conclusions
The data suggest not to stop ASA therapy prior to vitreoretinal surgery. Furthermore, we found no evidence of an increased risk for perioperative bleedings in patients under anticoagulation with vitamin-k antagonists with an INR within the sub-therapeutic range. SRD during scleral buckling procedure should be avoided as possible and regardless of any type of anticoagulation.
Similar content being viewed by others
References
Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J, American College of Chest P (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:299S–339S. https://doi.org/10.1378/chest.08-0675
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice G (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64:e1–e76. https://doi.org/10.1016/j.jacc.2014.03.022
Jaissle GB, Szurman P, Bartz-Schmidt KU, German Retina S, German Society of O, German Professional Association of O (2005) Recommendation for the implementation of intravitreal injections--statement of the German retina society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 222:390–395. https://doi.org/10.1055/s-2005-858231
Patel R, Charles S, Jalil A (2017) Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review. Graefes Arch Clin Exp Ophthalmol 255:1275–1285. https://doi.org/10.1007/s00417-017-3664-3
Feltgen N, Hoerauf H, Noske W, Hager A, Koscielny J (2016) Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions. Ophthalmologe 113:1010–1022. https://doi.org/10.1007/s00347-016-0368-8
Kumar N, Jivan S, Thomas P, McLure H (2006) Sub-Tenon’s anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 32:1022–1025. https://doi.org/10.1016/j.jcrs.2006.02.035
Nguyen QH, Budenz DL, Parrish RK 2nd (1998) Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol 116:571–575
Cobb CJ, Chakrabarti S, Chadha V, Sanders R (2007) The effect of aspirin and warfarin therapy in trabeculectomy. Eye (Lond) 21:598–603. https://doi.org/10.1038/sj.eye.6702277
Law SK, Song BJ, Yu F, Kurbanyan K, Yang TA, Caprioli J (2008) Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 145:736–746. https://doi.org/10.1016/j.ajo.2007.12.007
Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AK, Eke T, Sparrow JM, Group EPRU (2009) The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye (Lond) 23:10–16. https://doi.org/10.1038/sj.eye.6703069
Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD, Study of Medical Testing for Cataract Surgery T (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110:1784–1788. https://doi.org/10.1016/S0161-6420(03)00785-1
Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C (2012) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery. Retina 32:1868–1873. https://doi.org/10.1097/IAE.0b013e31825097ae
Fabinyi DC, O’Neill EC, Connell PP, Clark JB (2011) Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Exp Ophthalmol 39:878–884. https://doi.org/10.1111/j.1442-9071.2011.02575.x
Khuthaila MK, Hsu J, Chiang A, DeCroos FC, Milder EA, Setlur V, Garg SJ, Spirn MJ (2013) Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol 155:757–763, 763 e751-752. https://doi.org/10.1016/j.ajo.2012.11.004
Oh J, Smiddy WE, Kim SS (2011) Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 151:934–939 e933. https://doi.org/10.1016/j.ajo.2010.09.035
Chandra A, Jazayeri F, Williamson TH (2011) Warfarin in vitreoretinal surgery: a case controlled series. Br J Ophthalmol 95:976–978. https://doi.org/10.1136/bjo.2010.187526
Brown JS, Mahmoud TH (2011) Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 31:1983–1987. https://doi.org/10.1097/IAE.0b013e31821800cd
Mason JO 3rd, Gupta SR, Compton CJ, Frederick PA, Neimkin MG, Hill ML, Heersink MJ, Vail RS, White MF Jr, Feist RM, Thomley ML, Albert MA Jr (2011) Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology 118:543–547. https://doi.org/10.1016/j.ophtha.2010.07.005
Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussieres JS, Wallace S, Network AIotACT (2016) Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 374:728–737. https://doi.org/10.1056/NEJMoa1507688
Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 126:1630–1639. https://doi.org/10.1161/CIRCULATIONAHA.112.105221
Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V, Investigators BC (2013) Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 368:2084–2093. https://doi.org/10.1056/NEJMoa1302946
Rechenmacher SJ, Fang JC (2015) Bridging anticoagulation: Primum Non Nocere. J Am Coll Cardiol 66:1392–1403. https://doi.org/10.1016/j.jacc.2015.08.002
Azad R, Kumar A, Sharma YR, Rajpal (2004) Modified needle drainage. A safe and efficient technique of subretinal fluid drainage in scleral buckling procedure. Indian J Ophthalmol 52:211–214
Walter P, Hellmich M, Baumgarten S, Schiller P, Limburg E, Agostini H, Pielen A, Helbig H, Lommatzsch A, Rossler G, Mazinani B, Group VS (2017) Vitrectomy with and without encircling band for pseudophakic retinal detachment: VIPER study report no 2-main results. Br J Ophthalmol 101:712–718. https://doi.org/10.1136/bjophthalmol-2016-309240
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
The need for informed consent was waived in view of the retrospective nature of the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bemme, S., Lauermann, P., Striebe, N.A. et al. Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. Graefes Arch Clin Exp Ophthalmol 258, 961–969 (2020). https://doi.org/10.1007/s00417-019-04554-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04554-1